The coronavirus disease 2019 (COVID-19) pandemic has threatened the stability of global
healthcare, which is becoming an endemic issue. Despite the development of various …

Fusion is a key event for enveloped viruses, through which viral and cell membranes come
into close contact. This event is mediated by viral fusion proteins, which are divided into …

Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is a novel and highly
pathogenic coronavirus and is the causative agent of the coronavirus disease 2019 (COVID …

The infection of coronavirus initiates with the binding between its spike protein receptor
binding domain (RBD) and a human cellular receptor called angiotensin-converting enzyme …

SARS-CoV-2 has been shown to enter and infect human cells via interactions between
spike protein (S glycoprotein) and angiotensin-converting enzyme 2 (ACE2). As such, it may …

The COVID-19 pandemic has caused significant social and economic disruption across the
globe. Cellular entry of SARS-CoV-2 into the human body is mediated via binding of the …

Recently, a novel coronavirus, known as severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has raised global concerns, being the etiological agent of the current …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel coronavirus,
is the causative agent responsible for the spread of the COVID19 pandemic across the …

The COVID-19 pandemic continues to spread around the world, with several new variants
emerging, particularly those of concern (VOCs). Omicron (B. 1.1. 529), a recent VOC with …

The SARS-CoV-2 viral spike protein S receptor-binding domain (S-RBD) binds ACE2 on
host cells to initiate molecular events, resulting in intracellular release of the viral genome …